Ascendis Pharma shares are trading higher after Goldman Sachs and Jefferies raised their respective price targets on the stock.
Portfolio Pulse from Benzinga Newsdesk
Ascendis Pharma shares are trading higher following price target increases from Goldman Sachs and Jefferies.
August 13, 2024 | 7:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ascendis Pharma shares are experiencing a boost due to increased price targets from Goldman Sachs and Jefferies.
The increase in price targets from two major financial institutions, Goldman Sachs and Jefferies, is likely to positively influence investor sentiment and drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100